RU2011154576A - METHOD FOR CORRECTION OF ADDICTIVE BEHAVIOR - Google Patents

METHOD FOR CORRECTION OF ADDICTIVE BEHAVIOR Download PDF

Info

Publication number
RU2011154576A
RU2011154576A RU2011154576/15A RU2011154576A RU2011154576A RU 2011154576 A RU2011154576 A RU 2011154576A RU 2011154576/15 A RU2011154576/15 A RU 2011154576/15A RU 2011154576 A RU2011154576 A RU 2011154576A RU 2011154576 A RU2011154576 A RU 2011154576A
Authority
RU
Russia
Prior art keywords
correction
addictive behavior
drugs
administered
course
Prior art date
Application number
RU2011154576/15A
Other languages
Russian (ru)
Other versions
RU2495670C2 (en
Inventor
Андрей Владимирович Михайлов
Наталья Валентиновна Михайлова
Басу ПОУДИАЛ
Original Assignee
Андрей Владимирович Михайлов
Наталья Валентиновна Михайлова
Басу ПОУДИАЛ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Андрей Владимирович Михайлов, Наталья Валентиновна Михайлова, Басу ПОУДИАЛ filed Critical Андрей Владимирович Михайлов
Priority to RU2011154576/15A priority Critical patent/RU2495670C2/en
Publication of RU2011154576A publication Critical patent/RU2011154576A/en
Application granted granted Critical
Publication of RU2495670C2 publication Critical patent/RU2495670C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

1. Способ коррекции аддиктивного поведения, включающий в себя введение в организм пациента органопрепаратов, отличающийся тем, что используют комбинацию из Hirnstamm D5, Placenta D5, Hypophysis D5, Thymus D5.2. Способ по п.1, отличающийся тем, что препараты вводят за 30-40 мин до приема пищи курсом длительностью в один месяц.3. Способ по п.1, отличающийся тем, что препараты вводят в сочетании с проведением курса психотерапии.4. Способ по п.1, отличающийся тем, что его применяют в отношении человека.1. A method for the correction of addictive behavior, including the introduction into the patient’s body of organics, characterized in that a combination of Hirnstamm D5, Placenta D5, Hypophysis D5, Thymus D5.2 is used. The method according to claim 1, characterized in that the drugs are administered 30-40 minutes before a meal with a course of one month. The method according to claim 1, characterized in that the drugs are administered in combination with a course of psychotherapy. The method according to claim 1, characterized in that it is applied to humans.

Claims (4)

1. Способ коррекции аддиктивного поведения, включающий в себя введение в организм пациента органопрепаратов, отличающийся тем, что используют комбинацию из Hirnstamm D5, Placenta D5, Hypophysis D5, Thymus D5.1. A method for the correction of addictive behavior, including the introduction into the patient’s body of organics, characterized in that a combination of Hirnstamm D5, Placenta D5, Hypophysis D5, Thymus D5 is used. 2. Способ по п.1, отличающийся тем, что препараты вводят за 30-40 мин до приема пищи курсом длительностью в один месяц.2. The method according to claim 1, characterized in that the drugs are administered 30-40 minutes before a meal with a course of one month. 3. Способ по п.1, отличающийся тем, что препараты вводят в сочетании с проведением курса психотерапии.3. The method according to claim 1, characterized in that the drugs are administered in combination with a course of psychotherapy. 4. Способ по п.1, отличающийся тем, что его применяют в отношении человека. 4. The method according to claim 1, characterized in that it is applied to humans.
RU2011154576/15A 2011-12-30 2011-12-30 Method for addictive behaviour correction RU2495670C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2011154576/15A RU2495670C2 (en) 2011-12-30 2011-12-30 Method for addictive behaviour correction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2011154576/15A RU2495670C2 (en) 2011-12-30 2011-12-30 Method for addictive behaviour correction

Publications (2)

Publication Number Publication Date
RU2011154576A true RU2011154576A (en) 2013-07-10
RU2495670C2 RU2495670C2 (en) 2013-10-20

Family

ID=48787482

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011154576/15A RU2495670C2 (en) 2011-12-30 2011-12-30 Method for addictive behaviour correction

Country Status (1)

Country Link
RU (1) RU2495670C2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2150938C1 (en) * 1997-01-15 2000-06-20 Григорьев Григорий Игоревич Method of treatment of patient with opium narcomania
AU2001247474A1 (en) * 2000-03-16 2001-09-24 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
RU2423117C2 (en) * 2003-07-02 2011-07-10 Сергей Михайлович Зенович Medication for reducing rate of progressing, prevention of development, prevention of onset of pathological processes induced by intake of ethanol and/or substances possessing addictive potential
RU2308297C2 (en) * 2005-12-16 2007-10-20 Тарас Николаевич Дудко Method for treating patients with different addictions

Also Published As

Publication number Publication date
RU2495670C2 (en) 2013-10-20

Similar Documents

Publication Publication Date Title
CY1124298T1 (en) FENFLURAMINE FOR USE IN THE THERAPEUTIC TREATMENT OF DRAVET SYNDROME
MY174727A (en) Stable, protracted glp-1/glucagon receptor co-agonists for medical use
PH12016500575A1 (en) Inhibitors of bruton`s tyrosine kinase
MX2020010412A (en) Inhibitors of bruton's tyrosine kinase.
PH12016500391A1 (en) Site-specific antibody conjugation methods and compositions
NZ720736A (en) Antibody drug conjugates (adcs) with kinesin spindel protein (ksp)
EA201390506A1 (en) POLYPEPTIDES THAT BIND THE COMPONENT C5 OF THE HUMAN COMPLEX
TWD161529S (en) Therapeutic lamp
PH12014501815A1 (en) Purinone compounds as kinase inhibitors
DOP2015000108A (en) PIRROLOPIRIMIDINE COMPOUNDS AS QUINASE INHIBITORS
EA201401028A1 (en) PHARMACEUTICAL COMPOSITION, CONTAINING EMAGOGLIFLOZIN AND MEDICINES FOR OBESITY
EA201500314A1 (en) DOSAGE FORMS OF ENZALUTAMIDE
EA201491617A1 (en) CONNECTIONS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY
EA201591839A1 (en) THERAPEUTIC PEPTIDES
MX366317B (en) Compositions and methods for treating chronic inflammation and inflammatory diseases.
EA201590136A1 (en) ARTIFICIAL CONSENSUS ALBUMIN-BINDING DOMAINS
TR201904980T4 (en) Pharmaceutical combinations comprising a B-Raf inhibitor, an EGFR inhibitor and optionally a PI3K-alpha inhibitor.
EA201690964A1 (en) COMPOSITIONS AND METHODS FOR REDUCING SERIOUS ADVERSE CARDIOVASCULAR PHENOMENA
BR112012013487A2 (en) AMANTADINE COMPOSITIONS AND METHODS OF USE
EA201171043A1 (en) COMPOSITIONS AND METHODS OF LONG-TERM THERAPY WITH THE USE OF AMINOPYRIDINES
BR112015010039A2 (en) treatment of cancer with pomalidomide in an individual with renal dysfunction
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
MX367926B (en) Pharmaceutical composition for a sustained release of lanreotide.
UA117933C2 (en) Stable polypeptides binding to human complement c5
MX2016006603A (en) Piperidine compounds having multimodal activity against pain.

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20141231